PlaxOpen the Plax feed →
Trade-margin cap on cancer drugs may push up costs elsewhere in supply chain: Experts
BusinessThe Hindu Business

Trade-margin cap on cancer drugs may push up costs elsewhere in supply chain: Experts

The Centre said the proposed trade margin cap could cut MRP of anti-cancer drugs by about 20% to 70%

Read the full story at thehindubusinessline.com ↗

Source: The Hindu Business (thehindubusinessline.com). Plax shows a short summary of the story. The full report belongs to the publisher.